Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer

Identification of molecular subtypes that reflect different prognoses and treatment responses, especially immune checkpoint inhibitors (ICIs) in esophageal squamous cell carcinoma (ESCC), is essential for treatment decisions. We performed targeted sequencing in 201 patients with ESCC to discover gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Mai, Zihang, Yuan, Jianye, Yang, Hong, Fang, Shuogui, Xie, Xiuying, Wang, Xinye, Xie, Jiaxin, Wen, Jing, Fu, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462502/
https://www.ncbi.nlm.nih.gov/pubmed/35993362
http://dx.doi.org/10.1172/jci.insight.155218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462502/
https://www.ncbi.nlm.nih.gov/pubmed/35993362
http://dx.doi.org/10.1172/jci.insight.155218

Ejemplares similares